According to Jean-Christophe Renauld, immunologist and researcher at UCLouvain, the main current challenge lies in the ability of pharmaceutical companies to rapidly produce the vaccine in sufficient quantities. But solutions exist to go faster, according to MP Catherine Fonck, who urges the government to review its strategy, drawing inspiration in particular from what is being done in Denmark and Germany.
I hope you are in health and well.
I offer you important instructions regarding this article
- The article has been translated based on the content of the source link below these instructions
If there is any problem related to the content, copyright, correctness of the information contained in this article, or If there are errors in the language, please leave a report below the article. or contact us via email [email protected]. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
- We only want readers to access information quickly and easily using other multilingual content, rather than information only available in a specific language.
- We always respect the copyright of the author's content and always include the original link of the source article, and if the author does not agree, leave the report below the article, the article will be edited or deleted at the author's request. Thank you so much! Warm greetings!